S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway
Leying Zhang(City Of Hope National Medical Center), Behnam Badie(City Of Hope National Medical Center), Sam Badie(City Of Hope National Medical Center), Wei Liu(Shandong University), Darya Alizadeh(CTI BioPharma (United Kingdom)), Omar Farrukh(City Of Hope National Medical Center), Dongchang Zhao(Baylor College of Medicine), Jeffrey Lin(Cancer Research Institute)
Cited by 82
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
|Cancer Immunology Research|2019|437
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216